Acute ischaemic stroke associated with SARS-CoV-2 infection in North America
Adam A Dmytriw,Mahmoud Dibas,Kevin Phan,Aslan Efendizade,Johanna Ospel,Clemens Schirmer,Fabio Settecase,Manraj K S Heran,Anna Luisa Kühn,Ajit S Puri,Bijoy K Menon,Sanjeev Sivakumar,Askan Mowla,Daniel Vela-Duarte,Italo Linfante,Guilherme C Dabus,Robert W Regenhardt,Salvatore D'Amato,Joseph A Rosenthal,Alicia Zha,Nafee Talukder,Sunil A Sheth,Ameer E Hassan,Daniel L Cooke,Lester Y Leung,Adel M Malek,Barbara Voetsch,Siddharth Sehgal,Ajay K Wakhloo,Mayank Goyal,Hannah Wu,Jake Cohen,Sherief Ghozy,David Turkel-Parella,Zerwa Farooq,Justin E Vranic,James D Rabinov,Christopher J Stapleton,Ramandeep Minhas,Vinodkumar Velayudhan,Zeshan Ahmed Chaudhry,Andrew Xavier,Maria Bres Bullrich,Sachin Pandey,Luciano A Sposato,Stephen A Johnson,Gaurav Gupta,Priyank Khandelwal,Latisha Ali,David S Liebeskind,Mudassir Farooqui,Santiago Ortega-Gutierrez,Fadi Nahab,Dinesh V Jillella,Karen Chen,Mohammad Ali Aziz-Sultan,Mohamad Abdalkader,Artem Kaliaev,Thanh N Nguyen,Diogo C Haussen,Raul G Nogueira,Israr Ul Haq,Osama O Zaidat,Emma Sanborn,Thabele M Leslie-Mazwi,Aman B Patel,James E Siegler,Ambooj Tiwari,North American Neurovascular COVID-19 (NAN-C) Consortium & Society of Vascular and Interventional Neurology (SVIN) Investigators
DOI: https://doi.org/10.1136/jnnp-2021-328354
Abstract:Background: To analyse the clinical characteristics of COVID-19 with acute ischaemic stroke (AIS) and identify factors predicting functional outcome. Methods: Multicentre retrospective cohort study of COVID-19 patients with AIS who presented to 30 stroke centres in the USA and Canada between 14 March and 30 August 2020. The primary endpoint was poor functional outcome, defined as a modified Rankin Scale (mRS) of 5 or 6 at discharge. Secondary endpoints include favourable outcome (mRS ≤2) and mortality at discharge, ordinal mRS (shift analysis), symptomatic intracranial haemorrhage (sICH) and occurrence of in-hospital complications. Results: A total of 216 COVID-19 patients with AIS were included. 68.1% (147/216) were older than 60 years, while 31.9% (69/216) were younger. Median [IQR] National Institutes of Health Stroke Scale (NIHSS) at presentation was 12.5 (15.8), and 44.2% (87/197) presented with large vessel occlusion (LVO). Approximately 51.3% (98/191) of the patients had poor outcomes with an observed mortality rate of 39.1% (81/207). Age >60 years (aOR: 5.11, 95% CI 2.08 to 12.56, p<0.001), diabetes mellitus (aOR: 2.66, 95% CI 1.16 to 6.09, p=0.021), higher NIHSS at admission (aOR: 1.08, 95% CI 1.02 to 1.14, p=0.006), LVO (aOR: 2.45, 95% CI 1.04 to 5.78, p=0.042), and higher NLR level (aOR: 1.06, 95% CI 1.01 to 1.11, p=0.028) were significantly associated with poor functional outcome. Conclusion: There is relationship between COVID-19-associated AIS and severe disability or death. We identified several factors which predict worse outcomes, and these outcomes were more frequent compared to global averages. We found that elevated neutrophil-to-lymphocyte ratio, rather than D-Dimer, predicted both morbidity and mortality.